Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation?

REFERENCES 1 Joshi R, Reingold AL, Menzies D, et al. Tuberculosis among healthcare workers in lowand middle-income countries: a systematic review. PLoS Med 2006; 3: e494. 2 Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-c assay. Am J Respir Crit Care Med 2006; 174: 349–355. 3 Christopher DJ, Daley P, Armstrong L, et al. Tuberculosis infection among young nursing trainees in South India. PLoS One 2010; 5: e10408. 4 Zwerling A, van den Hof S, Scholten J, et al. Interferon-c release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2011; [Epub ahead of print DOI: 10.1136/thx.2010.143180]. 5 Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746–2755. 6 World Health Organization. TB Data: Data Collected from TB Control Programmes and Estimates Generated by WHO. www. who.int/tb/country/data/download/en/index.html Date last accessed: October 30, 2010. Date last updated: 2010. 7 Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold1 in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011; 6: e17984. 8 Hill PC, Jackson-Sillah DJ, Fox A, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008; 3: e1379. 9 Bakir M, Millington KA, Soysal A, et al. Prognostic value of a Tcell-based, interferon-c biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149: 777–787. 10 Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-c release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One 2010; 5: e10508. 11 del Corral H, Paris SC, Marin ND, et al. IFNc response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 2009; 4: e8257. 12 Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-c release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954–962. 13 Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood interferon-c release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2010; 183: 88–95. 14 Pai M. Spectrum of latent tuberculosis – existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010; 8: 242. 15 Barry CE, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7: 845–855. 16 Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956–973. 17 Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-c release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2011; [Epub ahead of print DOI: 10.1016/S1473-3099(11)70210-9].